| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/19/1998 | DE19632773A1 Neue Thrombininhibitoren New thrombin inhibitors |
| 02/19/1998 | DE19632772A1 Neue Benzamidine New benzamidines |
| 02/19/1998 | DE19632549A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
| 02/19/1998 | CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 02/19/1998 | CA2263416A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 02/19/1998 | CA2263220A1 Thrombin inhibitors |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2260854A1 Modified oligosaccharides |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823896A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | CN1173821A Methods of inhibiting cell-cell adhesion |
| 02/18/1998 | CN1173818A Pharmaceutical preparations for tumour necrosis factor (TNF) inhibition |
| 02/18/1998 | CN1173497A Heterocycle-containing carbonic acid derivatives |
| 02/18/1998 | CN1173356A Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture |
| 02/17/1998 | US5719306 LTA4 hydrolase inhibitors |
| 02/17/1998 | US5719186 Central muscle relaxants, anxiolytic agents, antiinflammatory agents, analgesics, anticonvulsants |
| 02/17/1998 | US5719184 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |
| 02/17/1998 | US5719173 Administering a benzimidazole carboxylate |
| 02/17/1998 | US5719163 Arthritis |
| 02/17/1998 | US5719158 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 02/17/1998 | US5719149 Morpholine derivatives and their use as therapeutic agents |
| 02/17/1998 | US5719140 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/17/1998 | US5719129 Sunscreen agents, antiaging agent, free radical scavenger |
| 02/17/1998 | CA2001727C Organic compounds |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005654A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 02/12/1998 | WO1998005637A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2? |
| 02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 02/12/1998 | WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998005328A1 Il-8 receptor antagonists |
| 02/12/1998 | WO1998005314A1 Novel stable liquid paracetamol compositions, and method for preparing same |
| 02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
| 02/12/1998 | CA2261783A1 1,2-diarylindole as cox-2 inhibitors |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
| 02/11/1998 | EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0630263B1 Pharmaceutical composition having site-specific delivery |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173179A Substituted 2 -(phosphinyloxymethyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173176A 2 -substituted 1, 2, 5 -thiadiazolidin-3 -one 1, 1-dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
| 02/11/1998 | CN1173131A 2 -(2, 3, 5, 6 -tetrafluoro -4 -phridyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
| 02/10/1998 | US5717083 Phosphoramidate and phosphorothiomidate oligomeric compounds |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5716991 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
| 02/10/1998 | US5716986 Lipoxygenase inhibitors |
| 02/10/1998 | US5716983 Use of coumarins and carbostyrils as PLA2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716967 Isoxazoline compounds as antiinflammatory agents |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716949 Heterocyclic compounds |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716942 Treatment of migraine with morpholine tachykinin receptor antagonists |
| 02/10/1998 | US5716934 Eck receptor ligands |
| 02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/05/1998 | WO1998004913A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | WO1998004555A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/05/1998 | WO1998004537A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 02/05/1998 | WO1998004281A1 Improved method of treating immune cell mediated systemic diseases |
| 02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 02/05/1998 | WO1998004276A1 Use in a composition of an extract of at least one labiate |
| 02/05/1998 | WO1998004249A2 Tramadol multiple unit formulations |
| 02/05/1998 | WO1998004247A1 Cell adhesion inhibitors |
| 02/05/1998 | WO1997048368A3 Naphthyridines which affect il-4 and g-csf |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | CA2262542A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2258609A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822192A2 Inhibitors of beta-glucuronidase |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821675A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors |
| 02/04/1998 | EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/1998 | EP0821551A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 02/04/1998 | EP0675721B1 Pharmaceutical compositions comprising contignasterol compounds |